Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

EyePoint, Inc.

Report topline results for clinical trials in DME

Deadline not yet reached (430 days left)

Announced
19 Oct 2026
Due
31 Dec 2027
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“our expectations regarding the timing of the availability of DME clinical data, including topline results for clinical trials in DME in the fourth quarter of 2027”
  • SourceEyePoint, Inc. Form 8-K press release, 2026-10-19
  • FilingSEC filing index
  • Deadline as statedin the fourth quarter of 2027
  • Deadline used31 Dec 2027, the last day of the stated period
  • TypeProduct
  • Permanent referenceKI-C-2026-EYPT-017655
    Cite as https://keptindex.org/c/KI-C-2026-EYPT-017655/ — this address never changes.

What we found

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 31 Dec 2027.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Deliverable
DME clinical trial topline results
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you EyePoint, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2026-EYPT-017655 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.